Reaction
Injection Site Scab reporting signals
As of the last recalculation, Injection Site Scab appears in 947 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is FLUTICASONE FUROATE (PRR 50.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fluticasone Furoate | 27 | 50.4 | 50.5 |
| Interferon Beta-1B | 28 | 33.1 | 33.1 |
| Glatiramer Acetate | 66 | 26.0 | 26.0 |
| Rosuvastatin Calcium | 27 | 21.7 | 21.7 |
| Omalizumab | 58 | 15.9 | 15.9 |
| Lanreotide Acetate | 5 | 14.1 | 14.1 |
| Cabotegravir | 5 | 13.7 | 13.7 |
| Interferon Beta-1A | 87 | 10.8 | 10.8 |
| Pegvaliase-Pqpz | 4 | 10.7 | 10.7 |
| Naltrexone | 12 | 8.7 | 8.7 |
| Treprostinil | 46 | 8.4 | 8.4 |
| Alirocumab | 7 | 6.2 | 6.2 |
| Abaloparatide | 7 | 5.3 | 5.3 |
| Onabotulinumtoxina | 17 | 4.9 | 4.9 |
| Sarilumab | 5 | 4.2 | 4.2 |
| Galcanezumab-Gnlm | 5 | 3.5 | 3.5 |
| Evolocumab | 25 | 3.5 | 3.5 |
| Tirzepatide | 24 | 3.3 | 3.3 |